IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Gemini Therapeutics Inc

CUSIP: 36870G105 | 110 institutional holders

Quarters

Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q4 2022

Running Point Capital Advisors, LLC10,000
0.0% of portfolio›$13.5K
Ulland Investment Advisors, LLC0
0.0% of portfolio›$0
StyleTurnoverLocationFiled
Running Point Capital Advisors, LLC
10,000$13.5K0.0%Agg GrowthVery LowEl Segundo, CA2023-02-09
Ulland Investment Advisors, LLC
0$00.0%GrowthVery LowMinneapolis, MN2023-01-31